Optimizing the Expression of Human Dopamine Receptors in <i>Escherichia coli</i>

The human dopamine receptors D<sub>2S</sub> and D<sub>3</sub> belong to the group of G protein-coupled receptors (GPCRs) and are important drug targets. Structural analyses and development of new receptor subtype specific drugs have been impeded by low expression yields or re...

Full description

Bibliographic Details
Main Authors: Vanessa Boritzki, Harald Hübner, Anni Allikalt, Peter Gmeiner, Birgitta M. Wöhrl
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/16/8647
_version_ 1797523605108555776
author Vanessa Boritzki
Harald Hübner
Anni Allikalt
Peter Gmeiner
Birgitta M. Wöhrl
author_facet Vanessa Boritzki
Harald Hübner
Anni Allikalt
Peter Gmeiner
Birgitta M. Wöhrl
author_sort Vanessa Boritzki
collection DOAJ
description The human dopamine receptors D<sub>2S</sub> and D<sub>3</sub> belong to the group of G protein-coupled receptors (GPCRs) and are important drug targets. Structural analyses and development of new receptor subtype specific drugs have been impeded by low expression yields or receptor instability. Fusing the T4 lysozyme into the intracellular loop 3 improves crystallization but complicates conformational studies. To circumvent these problems, we expressed the human D<sub>2S</sub> and D<sub>3</sub> receptors in <i>Escherichia coli</i> using different N- and C-terminal fusion proteins and thermostabilizing mutations. We optimized expression times and used radioligand binding assays with whole cells and membrane homogenates to evaluate K<sub>D</sub>-values and the number of receptors in the cell membrane. We show that the presence but not the type of a C-terminal fusion protein is important. Bacteria expressing receptors capable of ligand binding can be selected using FACS analysis and a fluorescently labeled ligand. Improved receptor variants can thus be generated using error-prone PCR. Subsequent analysis of clones showed the distribution of mutations over the whole gene. Repeated cycles of PCR and FACS can be applied for selecting highly expressing receptor variants with high affinity ligand binding, which in the future can be used for analytical studies.
first_indexed 2024-03-10T08:45:20Z
format Article
id doaj.art-f583f29e869f4e3d8359052d7e4dfa50
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T08:45:20Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-f583f29e869f4e3d8359052d7e4dfa502023-11-22T07:58:26ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-012216864710.3390/ijms22168647Optimizing the Expression of Human Dopamine Receptors in <i>Escherichia coli</i>Vanessa Boritzki0Harald Hübner1Anni Allikalt2Peter Gmeiner3Birgitta M. Wöhrl4Department of Biochemistry IV—Biopolymers, Universität Bayreuth, Universitätsstr. 30, 95447 Bayreuth, GermanyDepartment of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger Str. 10, 91058 Erlangen, GermanyDepartment of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger Str. 10, 91058 Erlangen, GermanyDepartment of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger Str. 10, 91058 Erlangen, GermanyDepartment of Biochemistry IV—Biopolymers, Universität Bayreuth, Universitätsstr. 30, 95447 Bayreuth, GermanyThe human dopamine receptors D<sub>2S</sub> and D<sub>3</sub> belong to the group of G protein-coupled receptors (GPCRs) and are important drug targets. Structural analyses and development of new receptor subtype specific drugs have been impeded by low expression yields or receptor instability. Fusing the T4 lysozyme into the intracellular loop 3 improves crystallization but complicates conformational studies. To circumvent these problems, we expressed the human D<sub>2S</sub> and D<sub>3</sub> receptors in <i>Escherichia coli</i> using different N- and C-terminal fusion proteins and thermostabilizing mutations. We optimized expression times and used radioligand binding assays with whole cells and membrane homogenates to evaluate K<sub>D</sub>-values and the number of receptors in the cell membrane. We show that the presence but not the type of a C-terminal fusion protein is important. Bacteria expressing receptors capable of ligand binding can be selected using FACS analysis and a fluorescently labeled ligand. Improved receptor variants can thus be generated using error-prone PCR. Subsequent analysis of clones showed the distribution of mutations over the whole gene. Repeated cycles of PCR and FACS can be applied for selecting highly expressing receptor variants with high affinity ligand binding, which in the future can be used for analytical studies.https://www.mdpi.com/1422-0067/22/16/8647human dopamine receptorsexpression in <i>E. coli</i>GPCRprotein engineeringFACSradioligand binding
spellingShingle Vanessa Boritzki
Harald Hübner
Anni Allikalt
Peter Gmeiner
Birgitta M. Wöhrl
Optimizing the Expression of Human Dopamine Receptors in <i>Escherichia coli</i>
International Journal of Molecular Sciences
human dopamine receptors
expression in <i>E. coli</i>
GPCR
protein engineering
FACS
radioligand binding
title Optimizing the Expression of Human Dopamine Receptors in <i>Escherichia coli</i>
title_full Optimizing the Expression of Human Dopamine Receptors in <i>Escherichia coli</i>
title_fullStr Optimizing the Expression of Human Dopamine Receptors in <i>Escherichia coli</i>
title_full_unstemmed Optimizing the Expression of Human Dopamine Receptors in <i>Escherichia coli</i>
title_short Optimizing the Expression of Human Dopamine Receptors in <i>Escherichia coli</i>
title_sort optimizing the expression of human dopamine receptors in i escherichia coli i
topic human dopamine receptors
expression in <i>E. coli</i>
GPCR
protein engineering
FACS
radioligand binding
url https://www.mdpi.com/1422-0067/22/16/8647
work_keys_str_mv AT vanessaboritzki optimizingtheexpressionofhumandopaminereceptorsiniescherichiacolii
AT haraldhubner optimizingtheexpressionofhumandopaminereceptorsiniescherichiacolii
AT anniallikalt optimizingtheexpressionofhumandopaminereceptorsiniescherichiacolii
AT petergmeiner optimizingtheexpressionofhumandopaminereceptorsiniescherichiacolii
AT birgittamwohrl optimizingtheexpressionofhumandopaminereceptorsiniescherichiacolii